CRISPR Therapeutics CRSP Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from CRISPR Therapeutics’s reported figures.
The official record: CRISPR Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about CRISPR Therapeutics's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is CRISPR Therapeutics's invested capital?
- CRISPR Therapeutics (CRSP) reported invested capital of $2.18B in Q1 2026.
- How has CRISPR Therapeutics's invested capital changed year-over-year?
- CRISPR Therapeutics's invested capital increased by 20.2% year-over-year, from $1.81B to $2.18B.
- What is the long-term trend for CRISPR Therapeutics's invested capital?
- Over 5 years (2020 to 2025), CRISPR Therapeutics's invested capital has grown at a 26.2% compound annual growth rate (CAGR), from $557.04M to $1.78B.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).